The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome. [electronic resource]
Producer: 20060731Description: 519-22 p. digitalISSN:- 0300-0664
- Adrenalectomy
- Adrenocorticotropic Hormone -- blood
- Adult
- Drug Administration Schedule
- Humans
- Middle Aged
- Nelson Syndrome -- blood
- PPAR gamma -- metabolism
- Pituitary ACTH Hypersecretion -- metabolism
- Rosiglitazone
- Statistics, Nonparametric
- Thiazolidinediones -- therapeutic use
- Time Factors
- Treatment Failure
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.